74 related articles for article (PubMed ID: 38590799)
1. M-MDSCs mediated trans-BBB drug delivery for suppression of glioblastoma recurrence post-standard treatment.
Yu T; Wang K; Wang J; Liu Y; Meng T; Hu F; Yuan H
J Control Release; 2024 May; 369():199-214. PubMed ID: 38537717
[TBL] [Abstract][Full Text] [Related]
2. Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade.
Fortin BM; Pfeiffer SM; Insua-RodrÃguez J; Alshetaiwi H; Moshensky A; Song WA; Mahieu AL; Chun SK; Lewis AN; Hsu A; Adam I; Eng OS; Pannunzio NR; Seldin MM; Marazzi I; Marangoni F; Lawson DA; Kessenbrock K; Masri S
Nat Immunol; 2024 May; ():. PubMed ID: 38806707
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of TREM2 in central nervous system cancers and peripheral cancers.
Zhong J; Xing X; Gao Y; Pei L; Lu C; Sun H; Lai Y; Du K; Xiao F; Yang Y; Wang X; Shi Y; Bai F; Zhang N
Cancer Cell; 2024 May; ():. PubMed ID: 38788719
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma microenvironment-from biology to therapy.
Read RD; Tapp ZM; Rajappa P; Hambardzumyan D
Genes Dev; 2024 May; ():. PubMed ID: 38811170
[TBL] [Abstract][Full Text] [Related]
5. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
Umansky V; Blattner C; Gebhardt C; Utikal J
Cancer Immunol Immunother; 2017 Aug; 66(8):1015-1023. PubMed ID: 28382399
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions.
Liu J; Piranlioglu R; Ye F; Shu K; Lei T; Nakashima H
Front Cell Infect Microbiol; 2023; 13():1141034. PubMed ID: 37234776
[TBL] [Abstract][Full Text] [Related]
7. CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
Pant A; Hwa-Lin Bergsneider B; Srivastava S; Kim T; Jain A; Bom S; Shah P; Kannapadi N; Patel K; Choi J; Cho KB; Verma R; Yu-Ju Wu C; Brem H; Tyler B; Pardoll DM; Jackson C; Lim M
Oncoimmunology; 2024; 13(1):2338965. PubMed ID: 38590799
[TBL] [Abstract][Full Text] [Related]
8. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
9. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.
Xie Z; Ikegami T; Ago Y; Okada N; Tachibana M
Oncoimmunology; 2020; 9(1):1734268. PubMed ID: 32158627
[TBL] [Abstract][Full Text] [Related]
12. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
[TBL] [Abstract][Full Text] [Related]
13. Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis.
Puengel T; Lefere S; Hundertmark J; Kohlhepp M; Penners C; Van de Velde F; Lapauw B; Hoorens A; Devisscher L; Geerts A; Boehm S; Zhao Q; Krupinski J; Charles ED; Zinker B; Tacke F
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743140
[TBL] [Abstract][Full Text] [Related]
14. CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma.
Wang J; Saung MT; Li K; Fu J; Fujiwara K; Niu N; Muth S; Wang J; Xu Y; Rozich N; Zlomke H; Chen S; Espinoza B; Henderson M; Funes V; Herbst B; Ding D; Twyman-Saint Victor C; Zhao Q; Narang A; He J; Zheng L
J Exp Med; 2022 May; 219(5):. PubMed ID: 35404390
[TBL] [Abstract][Full Text] [Related]
15. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
Zhao Z; Zhang KN; Wang Q; Li G; Zeng F; Zhang Y; Wu F; Chai R; Wang Z; Zhang C; Zhang W; Bao Z; Jiang T
Genomics Proteomics Bioinformatics; 2021 Feb; 19(1):1-12. PubMed ID: 33662628
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
